[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350072-105":59,"doc-detail-350072-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","beyond-conventional-biomarkers-the-role-of-alpha-fetoprotein-in-gastroenteropancreatic-neuroendocrine-neoplasms","Beyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms","","Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are clinically and biologically diverse, and existing biomarkers often lack adequate sensitivity and specificity for diagnosis and prognosis. Alpha-fetoprotein (AFP), an established biomarker in other cancers, has been proposed as a potentially informative marker in GEP-NENs, though its clinical relevance remains uncertain. This narrative review evaluates AFP’s role by summarizing evidence from studies measuring circulating AFP levels in affected patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/beyond-conventional-biomarkers-the-role-of-alpha-fetoprotein-in-gastroenteropancreatic-neuroendocrine-neoplasms/350072/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/beyond-conventional-biomarkers-the-role-of-alpha-fetoprotein-in-gastroenteropancreatic-neuroendocrine-neoplasms/350072.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are current biomarkers for GEP-NENs considered insufficient?","Question",{"text":112,"@type":113},"Current biomarkers have limited sensitivity and specificity, which complicates both diagnosis and prognosis in gastroenteropancreatic neuroendocrine neoplasms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was AFP evaluated in this review?",{"text":117,"@type":113},"The review performed a search of PubMed, Scopus, and Web of Science up to December 1, 2025, including studies that reported measurable circulating AFP levels in GEP-NEN patients.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main clinical implication of AFP for GEP-NENs?",{"text":121,"@type":113},"AFP elevation is rare but consistently linked to advanced disease and more aggressive tumor features; however, its prognostic value decreases after adjusting for clinicopathological factors, so it is not supported as an independent biomarker.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350072,1790179412,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Review  \nPUBLISHED 19 March 2026  \nDOI 10.3389/fendo.2026.1778029  \nOPEN ACCESS  \nEDITED BY  \nMarialuisa Appetecchia,  \nHospital Physiotherapy Institutes (IRCCS), Italy  \nREVIEWED BY  \nWeipang Ho,  \nLinkou Chang Gung Memorial Hospital, Taiwan  \nMarilena Stoian,  \nCarol Davila University of Medicine and Pharmacy, Romania  \n*CORRESPONDENCE  \nAnna La Salvia  \n [anna.lasalvia@iss.it](anna.lasalvia@iss.it)  \nRECEIVED 30 December 2025  \nREVISED 26 February 2026  \nACCEPTED 04 March 2026  \nPUBLISHED 19 March 2026  \nCITATION  \nLa Salvia A and Fanciulli G (2026)  \nBeyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms.  \nFront. Endocrinol. 17:1778029 .  \ndoi: 10.3389/fendo.2026.1778029  \nCOPYRIGHT  \n© 2026 La Salvia and Fanciulli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nBeyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms  \nAnna La Salvia 1* and Giuseppe Fanciulli  2,3  \n1 National Center for Drug Research and Evaluation, National Institute of Health (ISS), Rome, Italy,  \n2 Neuroendocrine Tumor Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy, 3 Endocrine Unit, Azienda Ospedaliero-Universitaria (AOU) of Sassari, Sassari, Italy  \nBackground: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) represent a diverse group of tumors, ranging from well-differentiated neuroendocrine tumors to poorly differentiated neuroendocrine carcinomas. Current biomarkers for GEP-NENs are weak and lack sufﬁcient sensitivity and speciﬁcity, complicating diagnosis and prognosis. Alpha-fetoprotein (AFP), a wellestablished biomarker in other cancers, has been reported as a potentially useful biomarker also for GEP-NENs, but its clinical relevance remains unclear. This narrative review evaluates AFP’s role in GEP-NENs.  \nMaterials and methods: We conducted a systematic search of PubMed, Scopus, and Web of Science up to December 1, 2025, using MeSH terms and free-text keywords related to AFP and GEP NENs. Only studies reporting measurable circulating AFP levels in GEP-NENs patients were included. Eligible study designs comprised retrospective or prospective studies and interventional trials. Non-English publications, case reports, small case series, reviews, and editorials were excluded.  \nResults: We identiﬁed ten studies evaluating circulating AFP in GEP-NENs, comprising nine retrospective cohorts ’ studies and one prospective study. 2,132 patients were included, with AFP measurements available for 1,222 . AFP elevation was rare in GEP-NENs but consistently associated with advanced disease, high tumor grade, and increased proliferative activity. Elevated AFP levels correlated with poorer survival outcomes and higher treatment response rates in patients undergoing chemotherapy. However, despite these associations, the prognostic value of AFP diminished after adjusting for clinicopathological factors, limiting its role as an independent biomarker.  \nConclusions: Current evidence suggests that AFP identiﬁes biologically aggressive subsets of GEP-NENs, reﬂecting disease burden in speciﬁc contexts. While AFP should not be considered an independent biomarker, it holds potential as a contextual signal of aggressive tumor biology and as an adjunctive tool within integrated clinical and pathological frameworks.  \nKEYWORDS  \nAFP, circulating biomarkers, disease progression, gastroenteropancreatic neuroendocrine neoplasms, prognosis, tumor grade  \nFrontiers in Endocrinology 01 [frontiersin.org](front","cbCaioDnUDx9thvw","https://ap.wps.com/l/cbCaioDnUDx9thvw","pdf",1204029,11,"English","# Background\n# Materials and methods\n# Results\n# Conclusions","[{\"question\":\"Why are current biomarkers for GEP-NENs considered insufficient?\",\"answer\":\"Current biomarkers have limited sensitivity and specificity, which complicates both diagnosis and prognosis in gastroenteropancreatic neuroendocrine neoplasms.\"},{\"question\":\"How was AFP evaluated in this review?\",\"answer\":\"The review performed a search of PubMed, Scopus, and Web of Science up to December 1, 2025, including studies that reported measurable circulating AFP levels in GEP-NEN patients.\"},{\"question\":\"What is the main clinical implication of AFP for GEP-NENs?\",\"answer\":\"AFP elevation is rare but consistently linked to advanced disease and more aggressive tumor features; however, its prognostic value decreases after adjusting for clinicopathological factors, so it is not supported as an independent biomarker.\"}]","Beyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms | PDF",1790087020,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d0cf0f3a3a3a1604416a19d7dd2ed0e.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1bb9d18cbe07247c5913266d80b5def.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a6b1ce281a2e4797906116a2a845406.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/443db83ab2fe8af30b48e710d8a20187.webp",980,1385]